How Much Did Neogen Raise?
Funding & Key Investors

Neogen has secured $1B in total funding, with a recent strategic investment of $1B announced on December 15, 2021. This major enterprise-level funding underscores the company's significant position in the food and animal safety sectors.

What is Neogen?

Neogen
ManufacturingPharmaceuticalsHealth & Nutrition Products

Neogen Corporation, headquartered in Lansing, Michigan, is a global leader in developing, manufacturing, and marketing products for food and animal safety. The company operates across two primary segments: Food Safety and Animal Safety. The Food Safety division offers diagnostic test kits and complementary products designed to detect a wide array of contaminants and allergens in human food and animal feed, including pathogens, toxins, and residues. The Animal Safety segment provides a comprehensive suite of products such as veterinary instruments, pharmaceuticals, vaccines, disinfectants, and genomics testing services, catering to researchers and animal health professionals. Neogen's commitment to safety and quality extends across the entire food supply chain and animal health industry.

How much funding has Neogen raised?

Neogen has raised a total of $1B across 1 funding round:

2021

Debt

$1B

Debt (2021): $1B with participation from JPMorgan Chase and Goldman Sachs

Key Investors in Neogen

JPMorgan Chase

JPMorgan Chase is a leading global financial services firm providing investment banking, commercial banking, asset management, and financial transaction processing. Their involvement suggests a strong belief in Neogen's financial stability and growth potential.

Goldman Sachs

Goldman Sachs is a premier global investment banking and securities firm, offering a wide range of financial services including advisory, underwriting, and asset management. Their participation highlights Neogen's strategic importance and access to significant capital markets.

What's next for Neogen?

The recent major strategic investment signifies a pivotal moment for Neogen, likely enabling accelerated expansion of its product lines, further research and development into advanced diagnostic technologies, and potential market penetration into new geographical regions. This capital infusion is expected to bolster Neogen's capabilities in addressing evolving global challenges in foodborne illness prevention and animal health management, positioning the company for sustained growth and innovation in its critical markets.

See full Neogen company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturing
ManufacturingTextiles & Apparel
Industrial Machinery & EquipmentManufacturing
ManufacturingTextiles & Apparel

Frequently Asked Questions Regarding Neogen Financial Insights

What are the most recent funding rounds that Neogen has completed, and what were the funding rounds?
Neogen has recently completed 1 funding rounds: Debt on Dec 15, 2021.
What is the total amount of funding Neogen has raised to date?
Neogen has raised a total of $1B in funding to date.
How many funding rounds has Neogen completed?
Neogen has completed 1 funding rounds.
How much funding did Neogen raise in its most recent funding round?
Neogen raised $1B in its most recent funding round.
Who are the lead investors in Neogen's latest funding round?
The lead investor in Neogen's latest funding round was JPMorgan Chase. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Neogen's history?
The largest funding round in Neogen's history was $1B.
See more information about Neogen